verapamil has been researched along with Psychotic Disorders in 8 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Efficiency of verapamil was studied in secondary prophylaxis of phasic affective disorders, 50 patients with affective and schizoaffective psychoses were treated during 2 years." | 9.08 | [The use of verapamil for the prevention of relapses of affective and schizoaffective psychoses]. ( Raiushkin, VA, 1998) |
| "Efficiency of verapamil was studied in secondary prophylaxis of phasic affective disorders, 50 patients with affective and schizoaffective psychoses were treated during 2 years." | 5.08 | [The use of verapamil for the prevention of relapses of affective and schizoaffective psychoses]. ( Raiushkin, VA, 1998) |
| "Carbamazepine (CBZ) is used in neurology for the treatment of epilepsies and trigeminal neuralgia and in psychiatry for the prophylactic treatment of affective and schizoaffective psychoses." | 3.68 | Calcium antagonistic effects of carbamazepine as a mechanism of action in neuropsychiatric disorders: studies in calcium dependent model epilepsies. ( Bingmann, D; Düsing, R; Grunze, H; Liu, Z; Walden, J, 1992) |
| " After 4-year treatment, verapamil has been substituted for its retard dosage form--isoptin retard." | 1.31 | [Verapamil retard as a medication for the prevention of affective and schizoaffective psychosis relapses]. ( Raiushkin, VA, 2002) |
| "Pre-treatment with verapamil (10 and 20 mg/kg, i." | 1.31 | Behavioural and anti-psychotic effects of Ca2+ channel blockers in rhesus monkey. ( Dubey, MP; Kalsotra, A; Kumar, R; Nath, C; Palit, G, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raiushkin, VA | 2 |
| Palit, G | 1 |
| Kalsotra, A | 1 |
| Kumar, R | 1 |
| Nath, C | 1 |
| Dubey, MP | 1 |
| De Beaurepaire, R | 1 |
| Walden, J | 1 |
| Grunze, H | 1 |
| Bingmann, D | 1 |
| Liu, Z | 1 |
| Düsing, R | 1 |
| Höschl, C | 1 |
| Kozený, J | 1 |
| Adler, L | 1 |
| Duncan, E | 1 |
| Reiter, S | 1 |
| Angrist, B | 1 |
| Peselow, E | 1 |
| Rotrosen, J | 1 |
| Price, WA | 1 |
| Giannini, AJ | 1 |
2 trials available for verapamil and Psychotic Disorders
| Article | Year |
|---|---|
[The use of verapamil for the prevention of relapses of affective and schizoaffective psychoses].
Topics: Adult; Affective Disorders, Psychotic; Aged; Female; Humans; Male; Middle Aged; Psychotic Disorders; | 1998 |
Verapamil in affective disorders: a controlled, double-blind study.
Topics: Adult; Amitriptyline; Anxiety Disorders; Bipolar Disorder; Clinical Trials as Topic; Depressive Diso | 1989 |
6 other studies available for verapamil and Psychotic Disorders
| Article | Year |
|---|---|
[Verapamil retard as a medication for the prevention of affective and schizoaffective psychosis relapses].
Topics: Aged; Calcium Channel Blockers; Female; Humans; Middle Aged; Mood Disorders; Psychotic Disorders; Re | 2002 |
Behavioural and anti-psychotic effects of Ca2+ channel blockers in rhesus monkey.
Topics: Amphetamine; Animals; Behavior, Animal; Calcium Channel Blockers; Central Nervous System Stimulants; | 2001 |
Treatment of neuroleptic-resistant mania and schizoaffective disorders.
Topics: Antipsychotic Agents; Bipolar Disorder; Drug Synergism; Drug Therapy, Combination; Haloperidol; Huma | 1992 |
Calcium antagonistic effects of carbamazepine as a mechanism of action in neuropsychiatric disorders: studies in calcium dependent model epilepsies.
Topics: Animals; Calcium Channel Blockers; Carbamazepine; Epilepsy; Extracellular Space; Guinea Pigs; Hippoc | 1992 |
Effects of calcium-channel antagonists on tardive dyskinesia and psychosis.
Topics: Adult; Animals; Calcium Channel Blockers; Diltiazem; Dyskinesia, Drug-Induced; Humans; Infant, Newbo | 1988 |
Verapamil in acute psychosis.
Topics: Acute Disease; Humans; Psychotic Disorders; Schizophrenia; Verapamil | 1986 |